-
Mashup Score: 0Percutaneous Microaxial Left Ventricular Assist Device for Patients With Cardiogenic Shock - 10 month(s) ago
This comparative effectiveness research study compares percutaneous microaxial left ventricular assist device vs alternative treatments among patients presenting with acute myocardial infarction with cardiogenic shock.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI - 11 month(s) ago
May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that utilizing Impella during high-risk percutaneous coronary intervention (PCI) procedures may help physicians achieve a more complete revascularization compared to high-risk PCIs supported using an intra-aortic balloon pump (IABP). Previous studies have shown that a more complete…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @Abiomed Abiomed announced results of a third-party analysis showing that utilizing #Impella during high-risk #PCI procedures may help physicians achieve a more complete #revascularization compared to high-risk PCIs supported using an #IABP: https://t.co/Mhsm5XZ4sK
-
-
Mashup Score: 1
Percutaneous mechanical circulatory support (MCS) devices have become an integral component of the cardiovascular therapeutic armamentarium. With a growing burd
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Percutaneous mechanical circulatory support device use has high variability across countries: Chinese expert consensus on their use in interventional cardiology. https://t.co/fsmErx1wjU #PCI #Impella #ECMO #IABP #cardiotwitter @ESC_Journals @escardio https://t.co/r7g7PNQv0w
-
-
Mashup Score: 1New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more - 1 year(s) ago
The Heart Failure Society of America and International Society for Heart and Lung Transplantation worked together on the document, hoping their recommendations serve as a “critical roadmap” for clinicians.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more @ISHLT @HFSA #cardiology #cardiotwitter #ECMO #heartpumps #IABP https://t.co/xWCSa66x53
-
-
Mashup Score: 0FDA Update: Agency Recalls Datascope/Getinge Cardiosave Hybrid and Rescue IABP - American College of Cardiology - 1 year(s) ago
The U.S. Food and Drug Administration (FDA) announced a recall on Jan. 25 of the Datascope/Getinge Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) and Cardiosave Rescue IABP due to risk that a burst, leaking or torn balloon can cause blood to enter the IABP during therapy, resulting in patient harm. A compromised intra-aortic balloon causing “a blood back event” can lead to critical…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#FDAUpdate: @US_FDA announced a recall of the Datascope/Getinge Cardiosave Hybrid and Rescue #IABP due to risk of a compromised intra-aortic balloon causing a blood back event, resulting in patient harm. Learn more: https://t.co/GjYKOVGY6O
-
-
Mashup Score: 1
JoVE | Peer Reviewed Scientific Video Journal | Methods And Protocols – Video. JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles. JoVE is the world-leading producer and provider of science videos with the mission to improve scientific research, scientific journals, and education. Millions…
Source: www.jove.comCategories: Cardiologists, Latest HeadlinesTweet-
Steps for #IABP insertion @JoVEJournal led by @CvUnmc #IC fellow, Dr. Ganesh Gajanan!! @esbrilakis @JSillerMatula #RonZolty #MCS #ACCEarlyCareer #ACCFIT #ACCIC #UNMCIM @UNMC_IM https://t.co/XLnHZu4ps5 https://t.co/i8pvnjlPgA
-
-
Mashup Score: 0
The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic Balloon Pumps. Arrow International, LLC, a subsidiary of Teleflex, Inc, is recalling the pumps after receiving complaints that battery power is not lasting as long as expected. A fully charged battery should last 90 minutes, however, multiple users report the devices are…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @teleflex Arrow International, LLC, a Subsidiary of Teleflex, Inc, #recalls #Arrow #AutoCAT2, #AC3 #intra_aortic_balloon_pumps #IABP for unexpectedly short battery run times: https://t.co/2QDauwaf69
-
-
Mashup Score: 0Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care Providers - 1 year(s) ago
December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices, including limited supplies of IAB catheters, new Cardiosave IABPs, and Cardiosave IABP parts. Recommendations The FDA recommends that health care facilities and providers who use Getinge…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @GetingeGlobal The #FDA is alerting healthcare facilities of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (#IABP) devices, including limited supplies of #IAB_catheters, new #Cardiosave IABPs, and Cardiosave IABP parts: https://t.co/dpI1nPtMhp
-
-
Mashup Score: 0Supply chain problems: FDA warns of new shortage of intra-aortic balloon pumps, catheters and spare parts - 1 year(s) ago
The U.S. Food and Drug Administration (FDA) is warning health systems and healthcare providers that supply chain issues have resulted in a new shortage of certain Getinge/Maquet/Datascope intra-aortic balloon pumps (IABPs) and intra-aortic balloon (IAB) catheters. The shortage also includes spare parts related to those devices. The FDA is recommending that any customers currently using these…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Supply chain problems: #FDA warns of new shortage of intra-aortic balloon pumps, catheters and spare parts #cardiology #healthcare #IABP https://t.co/rlNWDv5HDX
-
-
Mashup Score: 0Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis - 2 year(s) ago
Impella was approved by the Food and Drug Administration in 2015 for use during high-risk percutaneous coronary interventions (PCIs); however, its safety and efficacy compared with intra-aortic balloon pump (IABP) has not been evaluated in contemporary practice and remains debated. We aimed to compare postapproval outcomes and costs of Impella versus IABP support for high-risk PCI in real-world…
Source: American Journal of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
This study from the @Yale demonstrates significant survival benefit in high-risk PCI with #Impella support In-🏥 survival was significantly ⤴️ with Impella compared to #IABP (unadjusted 95.3% vs. 91.0%, p=0.0002; adjusted OR 1.55, 95% CI 1.02, 2.36) https://t.co/hwoejkdijO https://t.co/wNldFylqaH
-
The recent observational study on Impella vs IABP or conservative management is, among many other things, a good example that no perfect way to adjust for confounders exist for observational studies! https://t.co/4qKw4TRpK6 @JAMACardio @Abiomed #IABP #Impella https://t.co/F2RFWrgC8B